Related Experiment Video
Updated: Jul 14, 2026

An In Vitro Approach to Photodynamic Therapy
Published on: August 17, 2018
Screening of photosensitizers-ATP binding cassette (ABC) transporter interactions in vitro
Shruti Vig1, Payal Srivastava1,2, Idrisa Rahman1,3,2
1Fischell Department of Bioengineering, University of Maryland, College Park, MD 20742, USA.
Abstract:
Aim: ATP-binding cassette (ABC) transporters are proteins responsible for the efflux of drug molecules from cancer cells, reducing the efficacy of anti-cancer treatments. This study assesses the susceptibility of a panel of clinically used photosensitizers to be transported by ABC transporters in vitro. Methods: The involvement of P-glycoprotein (P-gp/ABCB1), breast cancer resistance protein (BCRP/ABCG2), and multidrug resistance-associated protein 1 (MRP1/ABCC1) in the transport of 7 clinically utilized photosensitizers [benzoporphyrin derivative (BPD), temoporfin, redaporfin, talaporfin sodium, rose bengal, methylene blue, and indocyanine green] were investigated using human breast cancer cell lines following well-established protocols. Briefly, parental MCF-7 cells and sublines that overexpress P-gp (MCF-7 TX400), ABCG2 (MCF-7 MX100), or MRP1 (MCF-7/VP) were treated with photosensitizers with and without ABC transporter inhibitors. Intracellular levels of photosensitizers were measured using extraction method and flow cytometry to determine whether the ABC transporters are associated with efflux or uptake of photosensitizers. Results: The ABCG2 inhibitor (fumitremorgin C) and P-gp inhibitor (valspodar) effectively blocked the transport mediated by ABCG2 and P-gp of rose bengal and BPD. Redaporfin showed increased accumulation in the presence of valspodar with flow cytometry. Interestingly, MCF-7/VP cells were found to have reduced intracellular accumulation of rose bengal, which was restored with MRP1 inhibitor (MK571). The cell viability assay showed photodynamic therapy (PDT) resistance with Redaporfin in P-gp-overexpressing cells, BPD in ABCG2- and P-gp-overexpressing cells, and with Rose bengal in ABCG2-, P-gp- and MRP1-overexpressing cells, respectively. However, no change in intracellular retention was observed for other photosensitizers. Conclusion: In summary, our study provided new knowledge that temoporfin, talaporfin sodium, methylene blue, and indocyanine green are not substrates of ABCG2, P-gp, or MRP1. Redaporfin is a substrate for P-gp. BPD is a known substrate of ABCG2 and P-gp. Rose bengal is a substrate of ABCG2, P-gp, and MRP1. The results presented here indicate ABC transporter substrate status as a possible cause for cellular resistance to photodynamic therapy with rose bengal, redaporfin, and BPD.
Insights
Seven photosensitizers were tested for transport by ATP-binding cassette (ABC) transporters. Rose bengal, redaporfin, and benzoporphyrin derivative are substrates for ABC transporters, potentially causing photodynamic therapy resistance.
Area of Science:
- Biochemistry
- Pharmacology
- Oncology
Background:
- ATP-binding cassette (ABC) transporters mediate drug efflux from cancer cells, impacting therapeutic efficacy.
- Understanding photosensitizer interaction with ABC transporters is crucial for optimizing photodynamic therapy (PDT).
Purpose of the Study:
- To investigate the susceptibility of seven clinically used photosensitizers to ABC transporter-mediated efflux.
- To determine if specific ABC transporters (P-gp, BCRP, MRP1) affect photosensitizer intracellular accumulation and PDT efficacy.
Main Methods:
- Utilized human breast cancer cell lines overexpressing P-gp (ABCB1), BCRP (ABCG2), or MRP1 (ABCC1).
- Assessed photosensitizer intracellular levels via flow cytometry with and without ABC transporter inhibitors.
- Evaluated cell viability post-PDT to correlate transporter activity with treatment resistance.
Main Results:
- Rose bengal, benzoporphyrin derivative (BPD), and redaporfin were identified as substrates for P-gp, BCRP, and/or MRP1.
- Temoporfin, talaporfin sodium, methylene blue, and indocyanine green were not substrates for these ABC transporters.
- Overexpression of ABC transporters led to PDT resistance for cells treated with rose bengal, redaporfin, and BPD.
Conclusions:
- Temoporfin, talaporfin sodium, methylene blue, and indocyanine green are not substrates of P-gp, BCRP, or MRP1.
- Rose bengal, redaporfin, and BPD interact with ABC transporters, influencing their intracellular accumulation and PDT efficacy.
- ABC transporter substrate status is a potential mechanism for cellular resistance to PDT with specific photosensitizers.
More Related Videos
13:17In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology
Published on: September 29, 2023
05:13LED-Based In Vitro Screening for Assessing Photoactivable Molecules in Bacterial Photodynamic Inactivation
Published on: January 24, 2025
Related Concept Videos
ABC Transporters: Exporter
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters